Search

Your search keyword '"Wang, Weixun"' showing total 24 results

Search Constraints

Start Over You searched for: Author "Wang, Weixun" Remove constraint Author: "Wang, Weixun" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
24 results on '"Wang, Weixun"'

Search Results

1. 2D-DPO: Scaling Direct Preference Optimization with 2-Dimensional Supervision

2. OpenRLHF: An Easy-to-use, Scalable and High-performance RLHF Framework

3. The N+ Implementation Details of RLHF with PPO: A Case Study on TL;DR Summarization

4. MARLlib: A Scalable and Efficient Multi-agent Reinforcement Learning Library

5. Off-Beat Multi-Agent Reinforcement Learning

6. A2C is a special case of PPO

7. Coach-assisted Multi-Agent Reinforcement Learning Framework for Unexpected Crashed Agents

8. Breaking the Curse of Dimensionality in Multiagent State Space: A Unified Agent Permutation Framework

9. Revisiting QMIX: Discriminative Credit Assignment by Gradient Entropy Regularization

13. Investigating Performance of the SLIM-Based High Resolution Ion Mobility Platform for Separation of Isomeric Phosphatidylcholine Species

14. Cooperative Multiagent Transfer Learning With Coalition Pattern Decomposition

15. MARLlib: A Scalable Multi-agent Reinforcement Learning Library

18. Discovery of Insulin Receptor Partial Agonists MK-5160 and MK-1092 as Novel Basal Insulins with Potential to Improve Therapeutic Index

19. Development of ProTx-II Analogues as Highly Selective Peptide Blockers of Nav1.7 for the Treatment of Pain

20. Guiding Chemically Synthesized Peptide Drug Lead Optimization by Derisking Mast Cell Degranulation-Related Toxicities of a NaV1.7 Peptide Inhibitor

21. Guiding Chemically Synthesized Peptide Drug Lead Optimization by Derisking Mast Cell Degranulation-Related Toxicities of a NaV1.7 Peptide Inhibitor.

22. Leveraging High-Resolution Ion Mobility-Mass Spectrometry for Cyclic Peptide Soft Spot Identification.

23. Development of ProTx-II Analogues as Highly Selective Peptide Blockers of Na v 1.7 for the Treatment of Pain.

24. A Series of Novel, Highly Potent, and Orally Bioavailable Next-Generation Tricyclic Peptide PCSK9 Inhibitors.

Catalog

Books, media, physical & digital resources